The Impact Of COVID-19: Experience In Nephrology
Leaders in nephrology will discuss healthcare challenges amidst COVID-19, telemedicine, and the future of nephrology.
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Featured Events
Events
The Impact Of COVID-19: Experience In Nephrology
Leaders in nephrology will discuss healthcare challenges amidst COVID-19, telemedicine, and the future of nephrology. *Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). Tazin Aijaz, PharmD, BCPS is an employee of OPDC. Featured Speakers Location Online via NephU.org
Overview Of Major Depressive Disorder (MDD) & Chronic Kidney Disease (CKD)/End-Stage Renal Disease (ESRD)
There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on CKD outcomes, and strategies for effective management of depression in CKD. Objectives Discuss the high […]
Major Depressive Disorder In Chronic Kidney Disease
A Virtual Live Event for PsychU & NephU members in the New York state region. There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on […]
Major Depressive Disorder In Chronic Kidney Disease
A regional Virtual Live Event for PsychU members in ID, NV, and NephU members in WA, OR, ID, AK, MT. There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the […]
Major Depressive Disorder In Chronic Kidney Disease
A regional Virtual Live Event for PsychU members in ID, NV, and NephU members in WA, OR, ID, AK, MT. There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the […]
Dietary Factors & Polycystic Kidney Disease (PKD): Dietary Interventions
This presentation on Dietary Factors & Polycystic Kidney Disease (PKD): Dietary Interventions, reviews human composite dietary intervention trials conducted in patients with autosomal dominant polycystic kidney disease (ADPKD). These dietary interventions include reductions in dietary sodium and protein to reduce solute load, increasing fluid intake to control vasopressin, and increasing fruit and vegetable intake to […]
Dietary Factors & Polycystic Kidney Disease (PKD): Dietary Interventions – 3pm Session
This presentation on Dietary Factors & Polycystic Kidney Disease (PKD): Dietary Interventions, reviews human composite dietary intervention trials conducted in patients with autosomal dominant polycystic kidney disease (ADPKD). These dietary interventions include reductions in dietary sodium and protein to reduce solute load, increasing fluid intake to control vasopressin, and increasing fruit and vegetable intake to […]
COVID-19 & Racism: The Impact Of Two Pandemics On Nephrology Care
Did you know that COVID-19 is affecting Black, Indigenous, Latinx and other people of color more than Caucasians? Did you know that in the United States, Black people are dying at 2.5 times the rate of White people?1 Please join us for a virtual panel discussion, led by nephrology and mental health experts from across […]
Patient Empowerment In The Age Of Technology
With the advancement of technology throughout the 21st century, we have seen a growing role for the utilization of information technology applied to health and healthcare. Health information technology (HIT), including HIT used by patients, can play an important role in patient empowerment by creating new opportunities for patients and families to participate actively in […]
Major Depressive Disorder In Chronic Kidney Disease
A regional Virtual Live Event for PsychU members in KS and OK, and NephU members in NM, OK, TX, and AR.There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the […]
Major Depressive Disorder In Chronic Kidney Disease
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology. This is a Regional Virtual Live Event for the Garden State Chapter of […]
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
